The 2019 European Hematology Association Annual Meeting is being held in Amsterdam, offering a program that is designed to teach, engage, and bring the hematology field together. Stay tuned for updates starting June 13th.
Targeting NADK Holds Promise in Treating NOTCH1-Driven T-Cell Acute Lymphoblastic Leukemia
Research presented at the 24th Congress of the European Hematology Association (EHA) found that potent inhibitors of NADK (NAD Kinase) could potentially enhance the...
EHA: Addition of Daratumumab to Standard of Care Improves Response in Newly Diagnosed Myeloma
Research presented at the European Hematology Association 24th Congress found that the addition of daratumumab to bortezomib, thalidomide, and dexamethasone
Breaking News from EHA 2019 in Amsterdam
Check out the latest news from the 24th Congress of the European Hematology Association.
Targeting NADK Holds Promise in Treating NOTCH1-Driven T-Cell Acute Lymphoblastic Leukemia
Research...
EHA: Voxelotor for Sickle Cell Disease Has Disease-Modifying Potential
European Hematology Association 24th Congress found that voxelotor significantly increased hemoglobin levels and reduced markers of hemolysis in patients with sickle cell disease.
Study Finds Gene Therapy Effective in Treating Thalassemia
Research presented last week at the 24th Congress of European Hematology Association (EHA) in Amsterdam found gene therapy to be effective in treating animal models of thalassemia....
Hem/Onc Journal Reading List
Advertisement